Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.
Stocks · News reference
Crude Oil Down Over 5%; McDonald's Earnings Top Views
U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22% to 26,490.24, S&P 500 up 1.64% to 7,725.48. Tech shares jump 3.8%, utilities down 0.5%. McDonald's beats earnings estimates. Ibotta, Backblaze, Corvex up, Adapthealth, Better Home & Finance, Clearpoint Neuro down.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of banks and financial services companies are trading higher as Treasury yields retreat and investors rotate out of AI-exposed stocks into sectors with more established cash flows and dividend prospects.
Better Home & Finance (BETR) Faces Securities Class Action Amid 75% Sequential Increase in Net Loss, Dimmed Loan Volume Prospects
Better Home & Finance faces a securities class action lawsuit after reporting a 75% sequential increase in net loss for Q1 2026 and drastically missing its $1 billion monthly loan volume target by 45%, achieving only $550 million per month. The company had previously assured investors it would reach the $1 billion target by May 2026, but failed to disclose that conversion rates were already slowing due to macroeconomic factors. The stock plunged 28% on May 7, 2026, and the CEO was subsequently fired.
Better Home & Finance Reports Preliminary Q3 Loan Volume Of $1.39B, Up 15%; Says ~$13.2M In Annualized Cost Cuts Implemented, $51M More Targeted
Needham Maintains Buy on Better Home & Finance, Lowers Price Target to $15
Needham analyst Kyle Peterson maintains Better Home & Finance (NASDAQ:BETR) with a Buy and lowers the price target from $25 to $15.
8-K filing — Ibotta, Inc. (IBTA)
Filed: 2026-09-24 AccNo: 0001628280-26-063400 Size: 169 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits